Zimbabwe has declined a significant American health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's insistence on confidential biological samples.
This move was revealed following a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesman later stated that the US was requesting biological samples for research and commercial gain but was unwilling to guarantee the benefits from future treatments.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to reach a deal suitable to all parties so the country's critical HIV programme can continue.
Wider Implications
This development comes after a comparable case in Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of citizens' health data.
Since returning to office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost openness and responsibility.
As per reports, 16 nations in Africa have to date signed similar agreements, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any corresponding guarantee of access to any medical innovations – like new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens should a future disease outbreak arise."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending systems already set up through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This system is designed to guarantee that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."
The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued discussions with our American counterparts on how subsequent collaboration might be structured in a manner that respects the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but suggested that talks should continue considering a large portion of the nation's HIV programmes depended on international support.
"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it added.
The situation emphasises the ongoing challenges between accepting vital foreign assistance and protecting national sovereignty in an ever more interconnected world.